Showing 161 - 180 results of 474 for search '"inflammation"', query time: 0.06s Refine Results
  1. 161

    Colonic cytokines for severe ulcerative colitis by Ye. A. Konovich, K. Ye. Shirokikh, I. L. Khalif, M. V. Shapina

    Published 2016-08-01
    “…Cytokine profile with the prevalence of IL-1β (IL-1β>IL-8>IL-6 (IFN-γ)>TNF-α) was observed in 14 (77,7%) of 18 biopsy specimens with moderate inflammation while similar cytokine pattern was observed in 9 (47,3%) of 19 biopsy specimens with severe inflammation (p=0,05). …”
    Get full text
    Article
  2. 162

    Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs by CUI Hanshu, LIU Bin

    Published 2025-01-01
    “…Some scholars believe that synovial inflammation is the main factor of pain and progression of OA, so disease-modifying anti-rheumatic drugs (DMARDs) for inflammatory arthritis could be used to treat OA. …”
    Get full text
    Article
  3. 163

    Thrombotic Complications in Inflammatory Bowel Disease by A. V. Borota, A. A. Borota, E. V. Onishchenko

    Published 2019-05-01
    “…In the сonditions under study, the presence of chronic inflammation and increased bleeding of the intestinal wall is shown to activate the coagulation system, impair the fibrinolysis system and reduce the activity of natural anticoagulation mechanisms. …”
    Get full text
    Article
  4. 164

    Antiviral therapy and regression of liver fibrosis at chronic hepatitis B by D. T. Abdurakhmanov

    Published 2010-02-01
    “…Now various strategies of influence on fibrosis are discussed, including elimination of etiological factor, suppression of inflammation and specific antifibrotic therapy.Conclusion. …”
    Get full text
    Article
  5. 165

    Contemporary treatment of right ventricular failure by Bibhuti B. Das, MD, Shashi Raj, MD, FAAP, FACC

    Published 2025-02-01
    “…The pathophysiology of RVF involves complex interactions, such as maladaptive hypertrophy, metabolic reprogramming, inflammation, fibrosis, apoptosis, and endothelial dysfunction. …”
    Get full text
    Article
  6. 166

    Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota by R. V. Maslennikov, Yu. V. Evsyutina

    Published 2018-09-01
    “…In the course of NAFLD, a change in the composition of the intestinal microbiota is observed, which contributes to the development of inflammation in the liver and disrupts the metabolism of bile acids, leading to insulin resistance.…”
    Get full text
    Article
  7. 167

    Metallothionein-3-mediated intracellular zinc mediates antioxidant and anti-inflammatory responses in the complete Freund’s adjuvant-induced inflammatory pain mouse model by Ngoc Buu Tran, Sook-Jeong Lee

    Published 2025-02-01
    “…Abstract Chronic inflammatory pain is often caused by peripheral tissue damage and persistent inflammation. This disease substantially affects patients’ physical and social well-being. …”
    Get full text
    Article
  8. 168

    Associations between brominated flame retardants exposure and non-alcoholic fatty liver disease: Mediation analysis in the NHANES by Yulan Cheng, Jingyi Su, Xiangdong Wang, Ruiyao Huang, Zixuan Zhao, Kai Tian, Tianxiang Gu, Xiaoke Wang, Lin Chen, Xinyuan Zhao

    Published 2025-01-01
    “…Furthermore, oxidative stress and chronic inflammation may mediate the effects of BFR exposure on NAFLD development.…”
    Get full text
    Article
  9. 169

    Comparative analysis of enteroscopy, computed tomography enterography, and intestinal ultrasound for the evaluation of small bowel Crohn’s disease by Bo Peng, Zhongcheng Liu, Zicheng Huang, Huixian Lin, Zhiyue Wang, Qin Guo

    Published 2025-02-01
    “…Methods: The differences in localization of disease lesions, mucosal inflammation, and transmural inflammation between enteroscopy, CTE, and intestinal ultrasound for evaluation of small bowel CD were compared. …”
    Get full text
    Article
  10. 170

    Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

    Published 2024-08-01
    “…The primary drivers of preexisting immunosuppression and inflammation are non-HIV infections and possibly alloantigen and drug exposures. …”
    Get full text
    Article
  11. 171

    Assisting significance of lncRNA ASB16-AS1 in the early detection and prognosis prediction of patients with deep venous thrombosis by Menglan Li, Yingying Li, Dawei Zhang, Cheng Cheng, Meiying Yang, Xiuyin Zhang, Xinming Yu, Bo Lu, Min Wang

    Published 2025-02-01
    “…The correlation of ASB16-AS1 with patients’ conditions, inflammation, and oxidative stress was evaluated by Spearman correlation analysis. …”
    Get full text
    Article
  12. 172

    Tannin alleviated reproductive dysfunction in pregnant ewes infected with Haemonchus contortus by Xin Li, Xin Li, Hai Xiang, Hai Xiang, Rong Liang, Rong Liang, Xinyu Han, Xinyu Han, Rongzhen Zhong, Rongzhen Zhong, Hongyu Liu, Hongyu Liu, Yi Fang, Yi Fang

    Published 2025-02-01
    “…After artificial insemination was completed, and the ewes were confirmed for pregnancy and infection; stools were collected for FEC, and blood samples were collected for PCV and CBC, hormonal, and inflammation levels. The mRNA levels of hypothalamic–pituitary–ovarian axis-related hormone receptors and placental tissue inflammation genes were detected by quantitative reverse transcription polymerase chain reaction (RT-qPCR). …”
    Get full text
    Article
  13. 173

    The Role of the Pathoanatomical Diagnosis «Chronic Gastritis» in the System of Personified Cancer Prevention by A. V. Kononov

    Published 2018-09-01
    “…The chronicle of cancer prevention is presented as an evolution of views on the possibility of clinical interpretation of structural changes in the gastric mucosa such as early (inflammation, metaplasia, atrophy) and pronounced (intraepithelial neoplasia/dysplasia) precancerous changes. …”
    Get full text
    Article
  14. 174

    Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction by M. V. Fadeeva, M. R. Skhirtladze, V. T. Ivashkin

    Published 2019-06-01
    “…The development of VT in patients with SIBOS is associated rather with systemic inflammation rather than with the severity of CHF. SIBOS can be considered as an additional risk factor in the development of systemic inflammation and ventricular tachycardia in patients with CHF.…”
    Get full text
    Article
  15. 175

    Investigating Non-steroidal Anti-Inflammatory Drugs as Potential Cancer Adjuncts: A Novel Approach to Cancer Therapy by Sadaf Alam, Leena Anjum, Muhammad Haneef

    Published 2025-02-01
    “…These drugs reduce inflammation and regulate key biological pathways involved in cancer progression, offering new avenues for prevention and therapy. …”
    Get full text
    Article
  16. 176

    Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases by O. V. Khlynova, E. A. Stepina

    Published 2018-11-01
    “…A positive correlation between the levels of VEGF and DEC and the markers of systemic inflammation (ESR, CRP and fibrinogen) has been revealed.Conclusion. …”
    Get full text
    Article
  17. 177

    Investigating Non-steroidal Anti-Inflammatory Drugs as Potential Cancer Adjuncts: A Novel Approach to Cancer Therapy by Sadaf Alam, Leena Anjum, Muhammad Haneef

    Published 2025-02-01
    “…These drugs reduce inflammation and regulate key biological pathways involved in cancer progression, offering new avenues for prevention and therapy. …”
    Get full text
    Article
  18. 178
  19. 179

    Potential of nutraceutical products for irritable bowel syndrome remission maintenance by A. I. Ulyanin, Ye. A. Poluektova, Ch. S. Pavlov, V. T. Ivashkin

    Published 2018-08-01
    “…These changes may be associated to development of inflammatory processes of intestinal wall. Long-term inflammation may result in nociceptor hypersensitivity i.e. peripheral sensitization that in turn, lead to the central sensitization and indirectly - to gastrointestinal tract (GIT) motility disorders. …”
    Get full text
    Article
  20. 180

    IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury by Liwu Zeng, Yaxin Wang, Yongzhou Huang, Wenchang Yang, Pei Zhou, Yaqi Wan, Kaixiong Tao, Ruidong Li

    Published 2025-02-01
    “…These findings suggest a new mechanism and potential treatment for promoting the resolution of inflammation and efferocytosis in autoimmune hepatitis.…”
    Get full text
    Article